Nadav Kidron, President and CEO, 10% Owner at ORAMED PHARMACEUTICALS INC. (ORMP), bought 2,600 shares at $3.80 ($10K) on 2015-03-18, disclosed to the SEC on 2015-03-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.78 | 500 | $2K | 18.7% |
| 2 | $3.80 | 500 | $2K | 18.8% |
| 3 | $3.92 | 1,100 | $4K | 42.8% |
| 4 | $3.95 | 400 | $2K | 15.7% |
| 5 | $4.00 | 100 | $400 | 4.0% |
| Total | $3.88 avg | 2,600 |
| $10K |
| 100% |
| Filing → |
| ORMP | SELL | 2021-08-11 | $4.4M | — | Filing → |
| ORMP | SELL | 2018-07-12 | $365 | — | Filing → |
| ORMP | BUY | 2018-07-12 | $722 | — | Filing → |